Ani Pharmaceuticals (ANIP) Buildings (2012 - 2013)

Ani Pharmaceuticals (ANIP) posted Buildings of $3.7 million for Q3 2013, little changed sequentially from $3.7 million in Q2 2013.

Ani Pharmaceuticals (ANIP) Buildings (2012 - 2013) Analysis & Trends

Ani Pharmaceuticals has reported Buildings for 2 years, with the latest figure at $3.7 million in Q3 2013.

Quarterly Buildings changed N/A year-over-year to $3.7 million in Q3 2013, while the trailing twelve-month figure through Sep 2013 was $3.7 million (changed N/A YoY) and the FY2012 annual result came in at $3.7 million, changed N/A from the prior year.
Buildings held at $3.7 million in Q3 2013 per ANIP's latest filing, from $3.7 million in the prior quarter.
Over five years, Buildings peaked at $3.7 million in Q4 2012 and troughed at $3.7 million in Q4 2012.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-
2	Teva Pharmaceutical Industries	43.28 Bn	39.62 Bn	2.15 Bn
3	Zoetis	31.79 Bn	30.11 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.69 Bn	22.89 Bn	5.10 Bn
5	United Therapeutics	22.25 Bn	19.58 Bn	683.80 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn
7	Neurocrine Biosciences	15.58 Bn	15.19 Bn	935.80 Mn
8	Elanco Animal Health	11.87 Bn	11.34 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-
10	Ani Pharmaceuticals	1.63 Bn	1.27 Bn	165.89 Mn

Download Data